Business Wire
BusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex Times
Back to front
Park Ha Biological Technology says it has begun cooperation with Amazon to support expansion into North American personal care
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 29, 10:31 AM EDT

Park Ha Biological Technology says it has begun cooperation with Amazon to support expansion into North American personal care

The Wuxi, China-based skincare and personal-care ingredient company, listed on the Nasdaq as BYAH, said the move is aimed at accelerating its global strategy and entering the North American market.

Park Ha Biological Technology Co., Ltd. announced June 29, 2026 that it has initiated cooperation with Amazon, framing the partnership as support for its planned entry into North America’s personal care sector and as a way to accelerate implementation of its broader global strategy.

In a statement distributed via Globe Newswire and carried by Yahoo Finance, the company said the cooperation represents “significant progress” in its global expansion efforts. The release was issued from Wuxi, China, where Park Ha is based.

Park Ha Biological is traded on the Nasdaq under the ticker BYAH. In its announcement, the company did not detail what the cooperation covers, such as whether it relates to technology services, logistics, sales channels, or marketing tools, nor did it provide financial terms tied to the effort.

The company’s wording emphasized market expansion and speed. It said the agreement is designed to help it enter North America’s personal care market, a category that typically includes products such as cosmetics, skin-care formulations, and hygiene-related items. Park Ha did not specify which product lines or applications are targeted first.

Amazon was not described in the announcement in terms of the specific business unit that would be involved. Amazon’s corporate newsroom describes its operations and news across retail, devices, and cloud computing, but Park Ha’s release, as summarized in the Yahoo posting, did not identify the precise scope of services or partners involved.

More broadly, the personal care supply chain has increasingly relied on cross-border commerce and on-demand distribution to reach new regions. In that context, partnerships tied to large online platforms can be a route to faster go-to-market execution, particularly for companies seeking to establish brand and product availability without building every component of distribution infrastructure from scratch.

Still, key commercial details remain unclear from the information disclosed in the announcement carried by Yahoo Finance. Park Ha did not report projected revenue impact, a timeline for North American market entry, or performance targets. It also did not disclose any milestones, pilot programs, or initial customer relationships connected to the cooperation.

For investors and industry watchers, the next useful data points will be whether Park Ha later provides specifics on the partnership’s operational scope and whether it offers updates on product rollout timing in North America, along with any measurable outcomes tied to the company’s stated global strategy.

Why It Matters

  • A cooperation with Amazon suggests Park Ha is looking for faster go-to-market capability as it targets North America’s personal care market.
  • If operational details are clarified later, the partnership could indicate which parts of Park Ha’s expansion strategy will be supported, such as distribution, digital sales, or technology enablement.
  • For the market, the move highlights how personal care and ingredient companies may use large platforms to accelerate regional entry.
  • The lack of disclosed milestones and terms means investors will likely watch subsequent updates for measurable traction and execution timelines.

Sources

Key Facts

  • Park Ha Biological Technology Co., Ltd. said it initiated cooperation with Amazon on June 29, 2026.
  • The company said the cooperation is intended to support its entry into the North American personal care sector.
  • Park Ha framed the step as progress toward implementing its global expansion strategy.
  • Park Ha Biological is listed on the Nasdaq under ticker BYAH.
  • The announcement carried by Yahoo Finance did not disclose the cooperation’s specific scope or financial terms.

Technology Related

Oct 23, 8:59 PM EDT
The Apex Times

Amazon shares among AI-infrastructure selloff targets as mega-cap tech resets

A broad pullback in AI infrastructure-linked equities has hit even companies whose financial results and demand indicators were described as holding up, according to a market-focused report. Amazon was cited alongside other large technology names as investors reassess near-term spending and competitive momentum.

Amazon shares among AI-infrastructure selloff targets as mega-cap tech resets
The Apex Times
Park Ha Biological Technology says it has begun cooperation with Amazon to support expansion into North American personal care | The Apex Times